Clinical studies showed that natriuretic peptides had the properties of dissolving and regulating lipid, and promoting lipid oxidation [7, 15, 16, 40], and cardiac TG content rose due to downregulation of cardiac BNP expression in animal models of obesity [40]. This evidence concerns the gene NPPB and obesity disorder.